@article{e7faf84de25d48f08b196af5e0a4e0d5,
title = "Twice-daily vs. Once-daily dolutegravir in patients with human immunodeficiency virus-tuberculosis coinfection receiving rifampicin-based tuberculosis therapy",
author = "Shin, {Sanghyuk S.} and Chawangwa Modongo and Zetola, {Nicola M.}",
note = "Funding Information: This study was funded in part by the US National Institutes of Health grant number K01AI118559.",
year = "2020",
month = jul,
day = "1",
doi = "10.1093/cid/ciz917",
language = "English (US)",
volume = "71",
pages = "242--243",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "1",
}
